Innate immunity in children and young people and the devastation of it if you take COVID vaccines
The innate immunity is our first line of defense and it is what protects children and they 'come' with it. It protects against many pathogen, include SARS-CoV-2. It protects against a range of virus and cancers, and it is non-specific and low-affinity. Does not have a memory alike adaptive/acquired immunity that is long-lived memory (natural immunity). Though we have indications of some 'learning' and 'training' by the innate immunity e.g. the innate antibodies...a very fascinating and interesting finding. Put a pin in that for now, but the focus here is that it is becoming known that the vaccinal antibodies can subvert and 'outcompete' the innate antibodies. This means that the normal existing innate antibodies that could usually neutralize and prevent infection in a healthy child etc., may now lose its capacity and thus leave children defenseless to other virus, SARS-2, and even cancers etc. There are reports that the second shot in some who has had COVID can damage the cellular immunity (T cell) and cause damage to the CD 8+ cytotoxic natural killer cells that are needed to fight cancers and other viruses. This is a big problem. Not only does the sub-optimal immune pressure from the vaccinal antibodies that intersects with the infectious pressure from the virus when there is mass vaccination during a pandemic, cause natural selection to select out variants that could overcome that immune pressure, but we have the huge concern of the innate antibodies being suppressed. This could become catastrophic for the population.
https://pubmed.ncbi.nlm.nih.gov/34697287/
There are also reports that vaccination on top of COVID recovered can cause adverse effects and immunity status should have been tested on first before any vaccine:
It appears to be very dangerous to layer inoculation on top of existing COVID recovered, naturally acquired immunity:
https://www.medrxiv.org/content/10.1101/2021.01.29.21250653v1
https://www.medrxiv.org/content/10.1101/2021.02.26.21252096v1
https://www.medrxiv.org/content/10.1101/2021.04.15.212521